HealthCare Global Enterprise Ltd (HCG), the Bangalore-headquartered pan-India chain of 20 super-speciality cancer care hospitals, is now seeking to expand abroad. The healthcare group, which till now has attracted Rs 150 crore of investments from private equity firms, will make its maiden foray abroad with its entry into
HCG said, it will set up a cancer division in a 400-bed hospital in
“We will use video conferencing facilities there and try to interconnect all hospitals of the group,” said Dr B S Ajaikumar, Chairman, HCG Enterprises Ltd.
The chain, which has 1,250 beds across its 20 hospitals in the country aims to add about 300 beds over the next year. Meanwhile, the group aims to go public by the end of next year.
While a multi-speciality hospital has an average EBITDA of 16 per cent, a super-speciality chain has EBITDA of 20 per cent. This is said to be the reason for super-speciality hospitals and hospital chains attracting more interest from investors.
The HCG has also acquired a six-acre plot of land on the way to Devanahalli from
Future plans of the group, he said, includes a cyberknife facility in Mumbai and
To make its facilities more affordable HCG has introduced the concept of paying the cost of treatment as EMIs. But, said Dr Ajaikumar, one hurdle to bringing down the cost of cancer treatment is the price of drugs many of which have patents still on them and are hence prohibitively priced.
The doctor hopes that in the near future he may be able to make cancer care affordable to more people. Once he gets the scale, he aims to approach the drug firms and try to get them to agree to payment for the drugs in EMIs just like the patients are able to do to secure treatment.